Assignee
REGULUS THERAPEUTICS INC
US·47 granted patents·30 pending applications·392 citations·filing 2004–2025
Top patents by PatentIndex Score
77 records- 0199US7683036B2Oligomeric compounds and compositions for use in modulation of small non-coding RNAsREGULUS THERAPEUTICS INC·Filed 2004·Granted Mar 23, 2010·182 cites·40 claims
- 0296US9359609B2Methods for treatment of alport syndromeREGULUS THERAPEUTICS INC·Filed 2015·Granted Jun 7, 2016·26 cites·20 claims
- 0396US7759319B2Oligomeric compounds and compositions for use in modulation of pri-mirnasREGULUS THERAPEUTICS INC·Filed 2006·Granted Jul 20, 2010·33 cites·20 claims
- 0495US9309513B2MicroRNA compounds and methods for modulating miR-122REGULUS THERAPEUTICS INC·Filed 2014·Granted Apr 12, 2016·13 cites·15 claims
- 0594US9506030B2Compounds and methods for enhanced cellular uptakeREGULUS THERAPEUTICS INC·Filed 2014·Granted Nov 29, 2016·18 cites·25 claims
- 0694US8912161B2MicroRNA compounds and methods for modulating miR-21 activityREGULUS THERAPEUTICS INC·Filed 2014·Granted Dec 16, 2014·15 cites·10 claims
- 0793US9574194B2MicroRNA compounds and methods for modulating miR-122REGULUS THERAPEUTICS INC·Filed 2016·Granted Feb 21, 2017·5 cites·34 claims
- 0893US9157083B2MicroRNA compounds and methods for modulating miR-122REGULUS THERAPEUTICS INC·Filed 2014·Granted Oct 13, 2015·9 cites·20 claims
- 0993US8859521B2Oligomeric compounds and compositions for use in modulation of small non-coding RNAsREGULUS THERAPEUTICS INC·Filed 2013·Granted Oct 14, 2014·7 cites·22 claims
- 1092US9267137B2MicroRNA compounds and methods for modulating miR-21 activityREGULUS THERAPEUTICS INC·Filed 2015·Granted Feb 23, 2016·8 cites·21 claims
- 1192US9012423B2Methods for treatment of alport syndromeREGULUS THERAPEUTICS INC·Filed 2013·Granted Apr 21, 2015·13 cites·26 claims
- 1291US9970007B2Targeting microRNAs for the treatment of fibrosisREGULUS THERAPEUTICS INC·Filed 2016·Granted May 15, 2018·6 cites·16 claims
- 1390US9688985B2MicroRNA compounds and methods for modulating miR-21 activityREGULUS THERAPEUTICS INC·Filed 2016·Granted Jun 27, 2017·6 cites·6 claims
- 1490US8969317B2MicroRNA compounds and methods for modulating miR-21 activityREGULUS THERAPEUTICS INC·Filed 2013·Granted Mar 3, 2015·9 cites·15 claims
- 1589US9139832B2Oligomeric compounds and compositions for use in modulation of small non-coding RNAsREGULUS THERAPEUTICS INC·Filed 2014·Granted Sep 22, 2015·4 cites·20 claims
- 1688US9790496B2Microrna compounds and methods for modulating MIR-21 activityREGULUS THERAPEUTICS INC·Filed 2015·Granted Oct 17, 2017·4 cites·15 claims
- 1787US9970011B2Methods for treatment of alport syndromeREGULUS THERAPEUTICS INC·Filed 2017·Granted May 15, 2018·4 cites·11 claims
- 1887US9752146B2Oligomeric compounds and compositions for use in modulation of small non-coding RNAsREGULUS THERAPEUTICS INC·Filed 2016·Granted Sep 5, 2017·2 cites·24 claims
- 1985US10150967B2MicroRNA compounds and methods for modulating miR-122REGULUS THERAPEUTICS INC·Filed 2017·Granted Dec 11, 2018·3 cites·20 claims
- 2084US10941400B2Compounds and methods for enhanced cellular uptakeREGULUS THERAPEUTICS INC·Filed 2019·Granted Mar 9, 2021·1 cites·17 claims
- 2184US9506062B2Targeting microRNAs for the treatment of liver cancerREGULUS THERAPEUTICS INC·Filed 2015·Granted Nov 29, 2016·3 cites·24 claims
- 2284US9181548B2Targeting micrornas for the treatment of fibrosisREGULUS THERAPEUTICS INC·Filed 2014·Granted Nov 10, 2015·3 cites·13 claims
- 2383US9150857B2Targeting microRNAs for the treatment of liver cancerREGULUS THERAPEUTICS INC·Filed 2014·Granted Oct 6, 2015·4 cites·26 claims
- 2483US2024141350A1Methods for treatment of polycystic kidney diseaseREGULUS THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2582US10301627B2Targeting microRNAs for the treatment of liver cancerREGULUS THERAPEUTICS INC·Filed 2017·Granted May 28, 2019·2 cites·24 claims
- 2682US9688986B2Methods for treatment of alport syndromeREGULUS THERAPEUTICS INC·Filed 2016·Granted Jun 27, 2017·2 cites·10 claims
- 2780US9447413B2Oligomeric compounds and compositions for use in modulation of small non-coding RNAsREGULUS THERAPEUTICS INC·Filed 2015·Granted Sep 20, 2016·1 cites·20 claims
- 2880US9267138B2Oligomeric compounds and compositions for use in modulation of small non-coding RNAsREGULUS THERAPEUTICS INC·Filed 2015·Granted Feb 23, 2016·1 cites·24 claims
- 2978US11168325B2Methods for treatment of polycystic kidney diseaseREGULUS THERAPEUTICS INC·Filed 2020·Granted Nov 9, 2021·1 cites·15 claims
- 3078US9447412B2Oligomeric compounds and compositions for use in modulation of small non-coding RNASREGULUS THERAPEUTICS INC·Filed 2013·Granted Sep 20, 2016·1 cites·14 claims
- 3178US7998677B2MicroRNA detectionREGULUS THERAPEUTICS INC·Filed 2009·Granted Aug 16, 2011·1 cites·16 claims
- 3278US2023109466A1Compositions for treatment of polycystic kidney diseaseREGULUS THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3377US9970009B2MicroRNA compounds and methods for modulating miR-21 activityREGULUS THERAPEUTICS INC·Filed 2017·Granted May 15, 2018·1 cites·20 claims
- 3477US2026055406A1Methods for treatment of polycystic kidney diseaseREGULUS THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 3576US10584336B2Oligomeric compounds and compositions for use in modulation of small non-coding RNAsREGULUS THERAPEUTICS INC·Filed 2018·Granted Mar 10, 2020·0 cites·19 claims
- 3676US10240151B2Compounds and methods for enhanced cellular uptakeREGULUS THERAPEUTICS INC·Filed 2016·Granted Mar 26, 2019·1 cites·21 claims
- 3775US10633657B2Methods for treatment of polycystic kidney diseaseREGULUS THERAPEUTICS INC·Filed 2016·Granted Apr 28, 2020·1 cites·20 claims
- 3875US2022213483A1Methods for treatment of polycystic kidney diseaseREGULUS THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3974US2021108205A1MicroRNA Compounds and Methods for Modulating MIR-122REGULUS THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 4073US10072265B2Oligomeric compounds and compositions for use in modulation of small non-coding RNAsREGULUS THERAPEUTICS INC·Filed 2017·Granted Sep 11, 2018·0 cites·20 claims
- 4173US2019144864A1MicroRNA Compounds and Methods for Modulating MIR-122REGULUS THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 4272US10138484B2Targeting microRNAs for metabolic disordersREGULUS THERAPEUTICS INC·Filed 2017·Granted Nov 27, 2018·1 cites·22 claims
- 4372US10093926B2Oligomeric compounds and compositions for use in modulation of small non-coding RNAsREGULUS THERAPEUTICS INC·Filed 2017·Granted Oct 9, 2018·0 cites·20 claims
- 4472US9528108B2Oligomeric compounds and compositions for use in modulation of small non-coding RNASREGULUS THERAPEUTICS INC·Filed 2014·Granted Dec 27, 2016·0 cites·21 claims
- 4572US2015094461A1Oligomeric compounds and compositions for use in modulation of small non-coding rnasREGULUS THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 4671US2025283082A1Compositions for Treatment of Polycystic Kidney DiseaseREGULUS THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 4770US2021095282A1Modified Oligonucleotides for Treatment of Polycystic Kidney DiseaseREGULUS THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 4869US9487783B2Targeting microRNAs for metabolic disordersREGULUS THERAPEUTICS INC·Filed 2015·Granted Nov 8, 2016·1 cites·8 claims
- 4969US2020392501A1Methods for treatment of polycystic kidney diseaseREGULUS THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 5067US9663787B2Oligomeric compounds and compositions for use in modulation of small non-coding RNAsREGULUS THERAPEUTICS INC·Filed 2015·Granted May 30, 2017·0 cites·21 claims
Showing the top 50 of 77 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →